Oxford Biomedica news. Headlines for OXB.

Oxford Biomedica News

Prices

Results Calendar charts

Charts

Watchlist

Share Tips

Here are all todays headlines related to Oxford Biomedica News. If you wish to drill deeper to view past Oxford Biomedica News items, follow the next 20 headlines link at the foot of the page.

Oxford Biomedica 'fully valued' as Jefferies ups target price

13-06-2018

Oxford Biomedica's long-awaited OXB-102 deal did not disappoint Jefferies, but analysts felt the share price was up with events.

Wednesday broker round-up

13-06-2018

Tate & Lyle: Jefferies downgrades to hold with a target price of 700p.

Sunday share tips: Oxford BioMedica, Avast, Savannah Resources

10-06-2018

Newspaper share tips from the Sunday Times on Oxford BioMedica, Sunday Telegraph on Avast and Mail on Sunday on Savannah Resources.

Oxford Biomedica inks licensing agreement with Axovant Sciences

06-06-2018

Gene and cell therapy group Oxford BioMedica has entered into an exclusive worldwide licensing agreement with Nasdaq-listed Axovant Sciences that will see the pair develop and commercialise OXB-102, a gene therapy for Parkinson's disease developed by the London-listed group.

Oxford BioMedica reaps rewards of Novartis' FDA approval

02-05-2018

Gene and cell therapy group Oxford BioMedica has seen Norvatis' chimeric antigen receptor T cell therapy, Kymriah, gain approval from the US Food and Drug Administration for intravenous infusion for its second indication, providing it with a significant boost.

Oxford Biomedica announces placing to inject £20.5m for expansion

09-03-2018

Oxford Biomedica intends to raise approximately £20.5m by way of a conditional placing of ordinary shares to raise money for expansion of bioprocessing facilities, the company said on Friday.

Oxford BioMedica signs collaboration agreement with Bioverativ

15-02-2018

Gene and cell therapy group Oxford BioMedica announced on Thursday that it has completed a major new collaboration and licence agreement with Bioverativ, for the development and manufacture of lentiviral vectors to treat haemophilia.

Next 20 headlines >>

Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk

Get a free widget for your website with our latest headlines.

You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.

Visit our widget builder